洞察类固醇诱导的ONFH:介质干细胞内表观遗传修饰的分子机制和功能
Chengxiong Huang1, Liming Qing1, Yu Xiao1
1Department of Orthopedics, Hand and Microsurgery, National Clinical Research Center of Geriatric Disorders, Xiangya Hospital of Central South University, Changsha 410008, China.
Biomolecules
|January 26, 2024
概括
中介细胞干细胞 (MSC) 显示出治疗类固醇诱导的股骨头骨硬化 (SONFH) 的前景. 表观遗传调节在MSC如何有效治疗这种具有挑战性的骨科疾病方面发挥着关键作用.
科学领域:
- 整形外科 整形外科 整形外科
- 再生医学是一种再生医学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 股骨头骨死 (ONFH) 是一种使人虚弱的骨科疾病,导致部疼痛和功能障碍.
- 目前对ONFH病变的理解包括凝血,脂质新陈代谢,分化失衡和血管修复受损.
- 有效预防和治疗ONFH仍然是重大的临床挑战.
研究的目的:
- 审查介质干细胞 (MSC) 中表观遗传调节的作用和分子机制,用于治疗类固醇诱导的ONFH (SONFH).
- 讨论最近的表观遗传研究对SONFH治疗策略的影响.
主要方法:
- 文献综述专注于MSC基于SONFH治疗中的表观遗传机制.
- 对参与表观遗传调节的分子通路的分析.
- 综合目前关于表观遗传学和SONFH的研究成果.
主要成果:
- 表观遗传修饰对于MSC功能和SONFH的治疗疗效至关重要.
- 特定的表观遗传机制影响与SONFH相关的MSCs的骨质和质分化.
- 了解这些机制可以优化SONFH的MSC治疗方法.
结论:
- 介质细胞干细胞为骨头的类固醇诱导骨硬化提供了一个有前途的治疗途径.
- 表观遗传调节是SONFH中MSC治疗成功的关键因素.
- 对表观遗传学的进一步研究可以导致对SONFH的改进和向治疗.
相关概念视频
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Stem Cell Niche
5.1K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.1K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


